Worcestershire Acute Hospitals NHS Trust, Worcester, UK
Hertford County Hospital, Hertford, UK.
Clin Med (Lond). 2020 Mar;20(2):219-220. doi: 10.7861/clinmed.2019-0465.
Thrombolytic treatment with tissue plasminogen activator is an established therapy for selected patients with ischaemic stroke within a narrow time window of 3 hours from the onset of symptoms. However, severe complications and poor outcomes are likely to ensue if a patient with acute aortic dissection is inadvertently treated with thrombolytic agents.We describe a patient presenting as facial droop, arm weakness, speech disturbance and time to call emergency services (FAST) positive (clinical picture of ischaemic stroke) who received thrombolysis and in whom the underlying diagnosis of acute thoracic aortic dissection was made by a combination of chance and a high clinical suspicion.
组织型纤溶酶原激活物溶栓治疗是一种已确立的疗法，适用于症状发作后 3 小时内的特定缺血性脑卒中患者。然而，如果急性主动脉夹层患者无意中接受溶栓药物治疗，则可能会出现严重并发症和不良后果。我们描述了一位表现为面瘫、手臂无力、言语障碍和呼叫急救服务时间（FAST）阳性（缺血性脑卒中的临床表现）的患者，该患者接受了溶栓治疗，而急性胸主动脉夹层的潜在诊断是通过偶然和高度临床怀疑相结合得出的。
